000 01715 a2200505 4500
005 20250518032750.0
264 0 _c20201105
008 202011s 0 0 eng d
022 _a2045-2322
024 7 _a10.1038/s41598-019-42245-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDong, Qiuju
245 0 0 _aPCC0208027, a novel tyrosine kinase inhibitor, inhibits tumor growth of NSCLC by targeting EGFR and HER2 aberrations.
_h[electronic resource]
260 _bScientific reports
_c04 2019
300 _a5692 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xdrug therapy
650 0 4 _aCell Line, Tumor
650 0 4 _aErbB Receptors
_xgenetics
650 0 4 _aFemale
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aMice, Nude
650 0 4 _aMutation
650 0 4 _aPiperazines
_xpharmacology
650 0 4 _aProtein Kinase Inhibitors
_xpharmacology
650 0 4 _aReceptor, ErbB-2
_xgenetics
650 0 4 _aReceptor, ErbB-4
_xgenetics
650 0 4 _aSignal Transduction
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aYu, Pengfei
700 1 _aYe, Liang
700 1 _aZhang, Jianzhao
700 1 _aWang, Hongbo
700 1 _aZou, Fangxia
700 1 _aTian, Jingwei
700 1 _aKurihara, Hiroshi
773 0 _tScientific reports
_gvol. 9
_gno. 1
_gp. 5692
856 4 0 _uhttps://doi.org/10.1038/s41598-019-42245-3
_zAvailable from publisher's website
999 _c29557295
_d29557295